Cutting fair-balance of drug TV ads

idonthetitThe Los Angeles Times  says that the FDA is studying whether limiting TV drug ad disclosure only to serious side effects would improve consumer understanding.  “Our hypothesis is that, relative to inclusion of the full major statement, providing limited risk information along with the disclosure about additional risks will promote improved consumer perception and understanding of serious and actionable drug risks,” the FDA said. Ha? Continue reading